These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
946 related items for PubMed ID: 32719751
1. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China. Han R, Shi Q, Wu S, Yin D, Peng M, Dong D, Zheng Y, Guo Y, Zhang R, Hu F, China Antimicrobial Surveillance Network (CHINET) Study Group. Front Cell Infect Microbiol; 2020; 10():314. PubMed ID: 32719751 [Abstract] [Full Text] [Related]
2. Efficacy of ceftazidime/avibactam and plazomicin on carbapenem-resistant Klebsiella pneumoniae and Escherichia coli. Öztaş S, Er DK, Dündar D, Keçeli SA. Acta Microbiol Immunol Hung; 2024 Jul 02; 71(2):110-120. PubMed ID: 38837219 [Abstract] [Full Text] [Related]
4. Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests. Laolerd W, Akeda Y, Preeyanon L, Ratthawongjirakul P, Santanirand P. Microb Drug Resist; 2018 Sep 02; 24(7):1006-1011. PubMed ID: 29782216 [Abstract] [Full Text] [Related]
7. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016). Wang Q, Wang X, Wang J, Ouyang P, Jin C, Wang R, Zhang Y, Jin L, Chen H, Wang Z, Zhang F, Cao B, Xie L, Liao K, Gu B, Yang C, Liu Z, Ma X, Jin L, Zhang X, Man S, Li W, Pei F, Xu X, Jin Y, Ji P, Wang H. Clin Infect Dis; 2018 Nov 13; 67(suppl_2):S196-S205. PubMed ID: 30423057 [Abstract] [Full Text] [Related]
10. Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam. Papadimitriou-Olivgeris M, Bartzavali C, Lambropoulou A, Solomou A, Tsiata E, Anastassiou ED, Fligou F, Marangos M, Spiliopoulou I, Christofidou M. J Antimicrob Chemother; 2019 Jul 01; 74(7):2051-2054. PubMed ID: 31002313 [Abstract] [Full Text] [Related]
11. Genetic Relatedness of NDM-Producing Klebsiella pneumoniae Co-Occurring VIM, KPC, and OXA-48 Enzymes from Surveillance Cultures from an Intensive Care Unit. Flores C, Bianco K, de Filippis I, Clementino MM, Romão CMCPA. Microb Drug Resist; 2020 Oct 01; 26(10):1219-1226. PubMed ID: 32283041 [Abstract] [Full Text] [Related]
13. Colonization of intestinal microbiota with carbapenemase-producing Enterobacteriaceae in paediatric intensive care units in Cairo, Egypt. Ghaith DM, Mohamed ZK, Farahat MG, Aboulkasem Shahin W, Mohamed HO. Arab J Gastroenterol; 2019 Mar 01; 20(1):19-22. PubMed ID: 30733176 [Abstract] [Full Text] [Related]
14. In-vitro activities of essential antimicrobial agents including aztreonam/avibactam, eravacycline, colistin and other comparators against carbapenem-resistant bacteria with different carbapenemase genes: A multi-centre study in China, 2021. Wu Y, Chen J, Zhang G, Li J, Wang T, Kang W, Zhang J, Sun H, Liu Y, Xu Y. Int J Antimicrob Agents; 2024 Nov 01; 64(5):107341. PubMed ID: 39304121 [Abstract] [Full Text] [Related]
15. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers. Martins AF, Bail L, Ito CAS, da Silva Nogueira K, Dalmolin TV, Martins AS, Rocha JLL, Serio AW, Tuon FF. Diagn Microbiol Infect Dis; 2018 Mar 01; 90(3):228-232. PubMed ID: 29223516 [Abstract] [Full Text] [Related]